https://www.selleckchem.com/products/AC-220.html
42-0.94, p=0.02), NANOG rs10744044 (any A allele vs G/G, HR=0.59, 95% CI=0.39-0.90, p=0.01), NANOGP8 rs2168958 (any C allele vs A/A, HR=2.12, 95% CI=1.36-3.29, p0.001)and NANOGP8 rs2279066 (any C allele vs T/T, HR=1.80, 95% CI=1.06-1.68, p=0.03). Multivariate analysis confirmed the significant associations for NANOGP8 rs2168958 and NANOGP8 rs2279066. In either bevacizumab cohort, no significant associations were observed in univariate analysis. Germ line polymorphisms in the PTFgenes could be predictive markers for cetuximab in mCRC.